• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

短期氟伐他汀治疗对冠心病心肌灌注的改善作用

Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease.

作者信息

Eichstädt H W, Eskötter H, Hoffman I, Amthauer H W, Weidinger G

机构信息

Department of Cardiology, Rudolf Virchow University Hospital, Free University of Berlin, Germany.

出版信息

Am J Cardiol. 1995 Jul 13;76(2):122A-125A. doi: 10.1016/s0002-9149(05)80033-5.

DOI:10.1016/s0002-9149(05)80033-5
PMID:7604786
Abstract

Patients with hypercholesterolemia have impaired coronary and peripheral endothelial function. In patients with coronary artery disease, intracoronary acetylcholine infusion or mental stress causes paradoxical vasoconstriction, whereas lowering cholesterol restores endothelial function. The impact of lipid lowering by fluvastatin on myocardial perfusion in hypercholesterolemic patients with perfusion abnormalities was assessed by thallium-201 single photon-emission computed tomography (SPECT). A total of 22 patients were treated with fluvastatin (40 mg once daily) for 6 weeks, followed by 40 mg twice daily if low density lipoprotein cholesterol (LDL-C) levels were decreased by < or = 30%. During the 12-week treatment period, myocardial perfusion was measured by quantitative SPECT after standardized stress testing at baseline and after 12 weeks. Preliminary results for 17 male patients (mean age, 59.3 +/- 6.7 years) are presented here. LDL-C decreased from 191 +/- 26 to 146 +/- 28 mg/dL (p < 0.001). In ischemic segments myocardial perfusion increased by 30% (280 +/- 100 to 365 +/- 110 counts per matrix; p < 0.001). In normal segments perfusion increased by only 5% (451 +/- 74 to 473 +/- 69 counts per matrix; p < 0.005). The change in perfusion rate between ischemic and normal segments was significant (p < 0.005). In conclusion, LDL-C lowering with short-term fluvastatin therapy improved myocardial perfusion, especially in areas of ischemia. This suggests that improvement is due to functional restoration of coronary endothelium by fluvastatin, before anatomic regression of stenosis can occur following long-term treatment.

摘要

高胆固醇血症患者存在冠状动脉和外周血管内皮功能受损。在冠状动脉疾病患者中,冠状动脉内注入乙酰胆碱或精神应激会导致反常的血管收缩,而降低胆固醇水平可恢复内皮功能。通过铊-201单光子发射计算机断层扫描(SPECT)评估氟伐他汀降低血脂对存在灌注异常的高胆固醇血症患者心肌灌注的影响。共有22例患者接受氟伐他汀治疗(每日40毫克,一次),为期6周;如果低密度脂蛋白胆固醇(LDL-C)水平降低幅度小于或等于30%,则随后改为每日两次,每次40毫克。在为期12周的治疗期间,于基线和12周后进行标准化应激试验后,通过定量SPECT测量心肌灌注。本文给出了17例男性患者(平均年龄59.3±6.7岁)的初步结果。LDL-C从191±26降至146±28毫克/分升(p<0.001)。在缺血节段,心肌灌注增加了30%(从每矩阵280±100计数增至365±110计数;p<0.001)。在正常节段,灌注仅增加了5%(从每矩阵451±74计数增至473±69计数;p<0.005)。缺血节段和正常节段之间的灌注率变化具有显著性(p<0.005)。总之,短期氟伐他汀治疗降低LDL-C可改善心肌灌注,尤其是在缺血区域。这表明这种改善是由于氟伐他汀使冠状动脉内皮功能恢复,而在长期治疗使狭窄发生解剖学消退之前。

相似文献

1
Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease.短期氟伐他汀治疗对冠心病心肌灌注的改善作用
Am J Cardiol. 1995 Jul 13;76(2):122A-125A. doi: 10.1016/s0002-9149(05)80033-5.
2
Fluvastatin in severe hypercholesterolemia: analysis of a clinical trial database.氟伐他汀治疗严重高胆固醇血症:一项临床试验数据库分析
Am J Cardiol. 1995 Jul 13;76(2):71A-75A. doi: 10.1016/s0002-9149(05)80022-0.
3
Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group.氟伐他汀与考来烯胺治疗后含载脂蛋白B血浆脂蛋白颗粒水平的变化。欧洲氟伐他汀研究组。
Am J Cardiol. 1995 Jul 13;76(2):65A-70A. doi: 10.1016/s0002-9149(05)80021-9.
4
Comparison of fluvastatin versus pravastatin treatment of primary hypercholesterolemia. French Fluvastatin Study Group.氟伐他汀与普伐他汀治疗原发性高胆固醇血症的比较。法国氟伐他汀研究组。
Am J Cardiol. 1995 Jul 13;76(2):54A-56A. doi: 10.1016/s0002-9149(05)80018-9.
5
Open-label study to assess the efficacy, safety, and tolerability of fluvastatin versus bezafibrate for hypercholesterolemia.一项开放标签研究,旨在评估氟伐他汀与苯扎贝特治疗高胆固醇血症的疗效、安全性和耐受性。
Am J Cardiol. 1995 Jul 13;76(2):57A-61A. doi: 10.1016/s0002-9149(05)80019-0.
6
Efficacy of fluvastatin, a totally synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. FLUENT Study Group. Fluvastatin Long-Term Extension Trial.氟伐他汀(一种全合成的3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂)的疗效。FLUENT研究组。氟伐他汀长期扩展试验。
Am J Cardiol. 1995 Jul 13;76(2):37A-40A. doi: 10.1016/s0002-9149(05)80014-1.
7
Beneficial effects of fluvastatin on myocardial blood flow at two time-points in hypercholesterolemic patients with coronary artery disease.氟伐他汀对冠心病高胆固醇血症患者两个时间点心肌血流的有益作用。
J Cardiovasc Pharmacol. 2000 May;35(5):735-40. doi: 10.1097/00005344-200005000-00009.
8
Efficacy and safety of triple therapy (fluvastatin-bezafibrate-cholestyramine) for severe familial hypercholesterolemia.三联疗法(氟伐他汀-苯扎贝特-考来烯胺)治疗重度家族性高胆固醇血症的疗效与安全性。
Am J Cardiol. 1995 Jul 13;76(2):84A-88A. doi: 10.1016/s0002-9149(05)80025-6.
9
Effect of fluvastatin for safely lowering atherogenic lipids in renal transplant patients receiving cyclosporine.氟伐他汀对接受环孢素治疗的肾移植患者安全降低致动脉粥样硬化血脂的作用。
Am J Cardiol. 1995 Jul 13;76(2):102A-106A. doi: 10.1016/s0002-9149(05)80028-1.
10
Outcome monitoring of fluvastatin in a Department of Veterans Affairs lipid clinic.退伍军人事务部脂质诊所中氟伐他汀的疗效监测
Am J Cardiol. 1995 Jul 13;76(2):62A-64A. doi: 10.1016/s0002-9149(05)80020-7.

引用本文的文献

1
Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development.脑胆固醇与阿尔茨海默病:探针和药物研发中的挑战与机遇。
Brain. 2024 May 3;147(5):1622-1635. doi: 10.1093/brain/awae028.
2
Failure to Launch: Targeting Inflammation in Acute Coronary Syndromes.启动失败:针对急性冠状动脉综合征中的炎症
JACC Basic Transl Sci. 2017 Aug 28;2(4):484-497. doi: 10.1016/j.jacbts.2017.07.001. eCollection 2017 Aug.
3
Fluvastatin for lowering lipids.氟伐他汀用于降血脂。
Cochrane Database Syst Rev. 2018 Mar 6;3(3):CD012282. doi: 10.1002/14651858.CD012282.pub2.
4
Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a prospective observational cohort study.他汀类药物治疗对脓毒症相关急性呼吸窘迫综合征(ARDS)患者死亡率的影响取决于ARDS的严重程度:一项前瞻性观察队列研究。
BMC Med. 2015 Jun 1;13:128. doi: 10.1186/s12916-015-0368-6.
5
[New aspects of perioperative statin therapy].围手术期他汀类药物治疗的新进展
Anaesthesist. 2010 Jun;59(6):539-48. doi: 10.1007/s00101-010-1725-7.
6
Long-term effects of a multimodal behavioral intervention on myocardial perfusion--a randomized controlled trial.多模式行为干预对心肌灌注的长期影响——一项随机对照试验
Int J Behav Med. 2009;16(3):219-26. doi: 10.1007/s12529-008-9030-4. Epub 2009 May 8.
7
The effects of atorvastatin therapy on endothelial function in patients with coronary artery disease.阿托伐他汀治疗对冠心病患者内皮功能的影响。
Cardiovasc Ultrasound. 2007 Dec 30;5:51. doi: 10.1186/1476-7120-5-51.
8
The importance of the link between coronary artery calcification and myocardial ischemia: a developing argument.冠状动脉钙化与心肌缺血之间联系的重要性:一个不断发展的论点。
J Nucl Cardiol. 2007 May-Jun;14(3):272-4. doi: 10.1016/j.nuclcard.2007.04.011.
9
Ongoing clinical trials of the pleiotropic effects of statins.关于他汀类药物多效性作用的正在进行的临床试验。
Vasc Health Risk Manag. 2005;1(1):29-40. doi: 10.2147/vhrm.1.1.29.58937.
10
Prognostic value of gated myocardial perfusion SPECT.门控心肌灌注单光子发射计算机断层扫描的预后价值
J Nucl Cardiol. 2004 Mar-Apr;11(2):171-85. doi: 10.1016/j.nuclcard.2003.12.004.